 Marinus Pharmaceuticals, Inc. NASDAQ:MRNS Q1 2022 Earnings Conference Call May 12, 2022 4:00 PM ET Company Participants Sasha Damouni Ellis - VP, Corporate Communications, and IR Scott Braunstein - Chief Executive Officer Joe Hulihan - Chief Medical Officer Steve Pfanstiel - Chief Financial Officer Mark Paternoster - Medicines Development Leader Christy Shafer - Chief Commercial Officer Conference Call Participants Marc Goodman - SVB Joseph Thome - Cowen Andrew Tsai - Jefferies Douglas Tsao - H.C. Wainwright Brian Skorney - Baird Joon Lee - Truist Securities Jay Olson - Oppenheimer Operator Greetings, and welcome to the Marinus Pharmaceuticals First Quarter 2022 Financial Results and Business Update Call. 